This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schulz, C. Articles by Lehnert, H. Search for Related Content PubMed PubMed Citation Articles by Schulz, C. Articles by Lehnert, H.

Central Nervous and Metabolic Effects of Intranasally Applied Leptin

Department of Endocrinology and Metabolism, Magdeburg University Medical School, Otto-von-Guericke University Magdeburg, 39120 Magdeburg, Germany

Address all correspondence and requests for reprints to: Dr. C. Schulz, Department of Endocrinology and Metabolism, Magdeburg University Medical School, 39120 Magdeburg, Germany. E-mail: carla. schulz{at}medizin.uni-magdeburg.de.

In obesity, due to the resistance of leptin receptors at the blood brain barrier, increased peripheral leptin levels cannot act appropriately at brain sites relevant for appetite regulation. In this study, we focused on the intranasal application of leptin. This mode of administration provides a promising tool for a direct access of peptides to the brain by circumventing the blood brain barrier. Male Wistar rats were treated daily with 0.1 or 0.2 mg/kg leptin intranasally for 4 wk. Compared with controls, leptin-treated animals gained significantly less weight and exhibited significantly reduced food and water intake. Corticotropin-releasing factor mRNA expression in the paraventricular nucleus showed a tendency for up-regulation by leptin; neuropeptide Y mRNA expression in the arcuate nucleus was decreased. In the central nucleus of the amygdala, corticotropin-releasing factor mRNA was significantly elevated in leptin-treated animals, suggesting a role in affective and/or emotional aspects of food intake. Serum leptin levels were unchanged, indicating a direct action of leptin in the central nervous system without prior access to the periphery. The intranasal application thus represents a useful tool to administer leptin in a noninvasive way with rapid permeation into the central nervous system.

This article has been cited by other articles:

				L. G. Bermudez-Humaran, S. Nouaille, V. Zilberfarb, G. Corthier, A. Gruss, P. Langella, and T. Issad Effects of Intranasal Administration of a Leptin-Secreting Lactococcus lactis Recombinant on Food Intake, Body Weight, and Immune Response of Mice Appl. Envir. Microbiol., August 15, 2007; 73(16): 5300 - 5307. [Abstract] [Full Text] [PDF]

				S. Perboni and A. Inui Anorexia in cancer: role of feeding-regulatory peptides Phil Trans R Soc B, July 29, 2006; 361(1471): 1281 - 1289. [Abstract] [Full Text] [PDF]

				S. Fliedner, C. Schulz, and H. Lehnert Brain Uptake of Intranasally Applied Radioiodinated Leptin in Wistar Rats Endocrinology, May 1, 2006; 147(5): 2088 - 2094. [Abstract] [Full Text] [PDF]